Stephen B. Wheatcroft
-
- Growth Hormone and Insulin-like Growth Factors 14
-
- Lipid metabolism and disorders 8
- Physiology top 2%
- Nitric Oxide and Endothelin Effects 19
- Immunology top 5%
- Atherosclerosis and Cardiovascular Diseases 10
-
- Angiogenesis and VEGF in Cancer 23
- Metabolism, Diabetes, and Cancer 12
-
- Cancer, Hypoxia, and Metabolism 13
-
- Adipokines, Inflammation, and Metabolic Diseases 8
- Co-authors
- Mark T. KearneyAjay M. ShahRichard M. CubbonSreenivasan PonnambalamEdward DuncanI. WilliamsVivienne EzzatJian‐Mei Li
- Partner nations
- United KingdomGermanyUnited States
In The Last Decade
Stephen B. Wheatcroft
94 papers receiving 3.6k citations
Peers
Comparison fields: 5 of 135
- Endocrinology, Diabetes and Metabolism 976
- Cardiology and Cardiovascular Medicine 1.1k
- Physiology 1.0k
- Endocrine and Autonomic Systems 169
- Immunology 505
Countries citing papers authored by Stephen B. Wheatcroft
This map shows the geographic impact of Stephen B. Wheatcroft's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen B. Wheatcroft with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen B. Wheatcroft more than expected).
Fields of papers citing papers by Stephen B. Wheatcroft
This network shows the impact of papers produced by Stephen B. Wheatcroft. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen B. Wheatcroft. The network helps show where Stephen B. Wheatcroft may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Stephen B. Wheatcroft, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 5 | |
| 3 | 2023 | 41 | |
| 4 | 2020 | 9 | |
| 5 | 2019 | 6 | |
| 6 | 2017 | 4 | |
| 7 | 2015 | 28 | |
| 8 | 2015 | 34 | |
| 9 | Abstract 13829: Endothelial Insulin Sensitisation Enhances Vascular Repair in Systemic Insulin Resistance and Improves Endothelial Function by Restoring Nitric Oxide Bioavailability | 2014 | 2 |
| 10 | 2014 | 36 | |
| 11 | 2014 | 18 | |
| 12 | Abstract 5847: IGF-1 Receptor and Insulin Receptor Stoichiometry is a Critical Determinant of Nitric Oxide Bioavailablity in vivo | 2009 | 1 |
| 13 | Abstract 3671: Dietary-induced Obesity in Mice results in Metabolic and Vascular Insulin-like Growth Factor 1 Resistance | 2008 | 1 |
| 14 | 2008 | 19 | |
| 15 | 2008 | 133 | |
| 16 | 2007 | 69 | |
| 17 | 2005 | 12 | |
| 18 | 2005 | 95 | |
| 19 | 2005 | 44 | |
| 20 | 2002 | 35 |
About Stephen B. Wheatcroft
Stephen B. Wheatcroft is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Cancer Research, having authored 97 papers that have together received 3.7k indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (23 papers), Nitric Oxide and Endothelin Effects (19 papers), Growth Hormone and Insulin-like Growth Factors (14 papers), Cancer, Hypoxia, and Metabolism (13 papers), Metabolism, Diabetes, and Cancer (12 papers), Atherosclerosis and Cardiovascular Diseases (10 papers), Adipokines, Inflammation, and Metabolic Diseases (8 papers) and Lipid metabolism and disorders (8 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (976 citations), Cardiology and Cardiovascular Medicine (1.1k citations) and Physiology (1.0k citations). Stephen B. Wheatcroft has collaborated with scholars based in United Kingdom, Germany and United States. Frequent co-authors include Mark T. Kearney, Ajay M. Shah, Richard M. Cubbon, Sreenivasan Ponnambalam, Edward Duncan, I. Williams, Vivienne Ezzat, Jian‐Mei Li, Sam L. Stephen and Shervanthi Homer‐Vanniasinkam. Their work appears in journals such as The Lancet, Circulation and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.